UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
(
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
|
(a) |
The Annual Meeting of Stockholders (“Annual Meeting”) of Tivity Health, Inc. (the “Company”) was held on May 20, 2021, at which a total of 44,527,414 shares of the Company's common stock, out of a total of 49,234,409 shares of the Company's common stock outstanding and entitled to vote, were present in person or represented by proxies. |
|
(b) |
The following proposals were voted upon at the Annual Meeting: |
|
(i) |
To elect Richard M. Ashworth, Sara J. Finley, Robert J. Greczyn, Jr., Beth M. Jacob, Bradley S. Karro, Erin L. Russell, and Anthony M. Sanfilippo as directors of the Company. The results of the election of the above-mentioned nominees were as follows: |
|
|
For |
|
Against |
|
Abstain from |
|
Broker |
Richard M. Ashworth |
|
42,320,729 |
|
64,681 |
|
5,173 |
|
2,136,831 |
Sara J. Finley |
|
41,768,085 |
|
617,997 |
|
4,501 |
|
2,136,831 |
Robert J. Greczyn, Jr. |
|
40,999,539 |
|
1,384,332 |
|
6,712 |
|
2,136,831 |
Beth M. Jacob |
|
42,122,125 |
|
257,180 |
|
11,278 |
|
2,136,831 |
Bradley S. Karro |
|
41,928,648 |
|
435,234 |
|
26,701 |
|
2,136,831 |
Erin L. Russell |
|
42,286,348 |
|
98,226 |
|
6,009 |
|
2,136,831 |
Anthony M. Sanfilippo |
|
42,250,406 |
|
119,269 |
|
20,908 |
|
2,136,831 |
|
|
|
|
|
|
|
|
|
|
(ii) |
To consider and act upon a non-binding, advisory vote to approve compensation of the Company's named executive officers. The voting results were as follows: |
For |
|
Against |
|
Abstain from |
|
Broker |
32,548,391 |
|
9,824,009 |
|
18,183 |
|
2,136,831 |
|
(iii) |
To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2021. The voting results were as follows: |
For |
|
Against |
|
Abstain from |
|
Broker |
44,472,461 |
|
46,555 |
|
8,398 |
|
N/A |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TIVITY HEALTH, INC. |
||
|
|
||
|
By: |
|
/s/ Adam Holland |
|
|
|
Name: Adam Holland |
|
|
|
Title: Chief Financial Officer |
Date: May 20, 2021
Document and Entity Information |
May 20, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 20, 2021 |
Entity Registrant Name | TIVITY HEALTH, INC. |
Entity Central Index Key | 0000704415 |
Entity Emerging Growth Company | false |
Entity File Number | 000-19364 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 62-1117144 |
Entity Address, Address Line One | 701 Cool Springs Boulevard |
Entity Address, City or Town | Franklin |
Entity Address, State or Province | TN |
Entity Address, Postal Zip Code | 37067 |
City Area Code | 800 |
Local Phone Number | 869-5311 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of each class | Common Stock - $.001 par value |
Trading Symbol | TVTY |
Name of each exchange on which registered | NASDAQ |
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